StonvexLoading…
StonvexStonvexStonvexCore line items from AAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $13.91B | $54.63B | $40.63B | $26.94B |
Operating Income | $-41.00M | $1.47B | $1.01B | $864.00M |
Net Income | $-382.00M | $111.00M | $12.00M | $599.00M |
EPS (Diluted) | $-0.58 | $0.17 | $0.02 | $0.19 |
Total Assets | $63.74B | $61.77B | $62.14B | $63.67B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.00B | $1.06B | $938.00M | $931.00M |
Free Cash Flow OCF − CapEx | $3.41B | $-680.00M | $1.22B | $2.10B |
Shares Outstanding | 661.39M | 660.30M | 660.06M | 659.80M |